FDA Inspection 1153025 — Sabina Zaharieva
The FDA completed an inspection of Sabina Zaharieva on September 10, 2021 in Sofiya. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sofiya (Bulgaria)
Additional Details
Clinical Investigator (CI)